Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
MLd4mmhescL1ekWy